Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart
Abundant evidence has correlated influenza infection with cardiovascular disease, yet mechanisms linking infection with the heart remain poorly understood.
Influenza vaccination and the risk of myocardial infarction: a meta-epidemiology study
The association between influenza vaccination and the risk of myocardial infarction (MI) remains incompletely characterized, particularly in real-world populations.
Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus–Related Hospitalization
In this self-controlled case series study of 11 887 patients, the risk of cardiorespiratory events after RSV-related hospitalization was significantly higher than during the control period.
News
Policy & Recommendations
New measures to make EU health sector more innovative, competitive and resilient
The European Commission has launched an ambitious package of measures to improve the health of EU citizens while strengthening the long-term resilience and competitiveness of the health sector.
Vaccination is vital to cardiovascular prevention, say heart specialists
The Society has published a Clinical Consensus Statement in the European Heart Journal highlighting the key role of vaccination in preventing cardiovascular events.
|
10th ESWI Influenza Conference 2025
When Infections Meet NCDs: The Bidirectional Relationship Between Cardiometabolic Conditions and Respiratory Viruses
Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
The pooled dataset encompassed 466,320 individually randomized participants, of whom 107,700 (23.1%) had a history of CVD.
Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta‐Analysis
In self‐controlled case series studies, laboratory‐confirmed influenza infection was associated with an elevated risk of acute myocardial infarction and stroke during the first 1 month.
